Stryker Corporation
SYK
A$614.71
Share price
-0.03%
Change (1 day)
20.65%
Change (1 year)
Categories
Stryker Corporation is an American company that manufactures orthopedic and surgical implants and instruments as well as products for patient transportation.
Revenue for Stryker Corporation (SYK)
Revenue in 2025 (TTM): A$35.81 Billion
According to Stryker Corporation's latest financial reports the company's current revenue (TTM 
) is A$35.63 Billion. In 2024 the company made a revenue of A$36.32 Billion an increase over the revenue in the year 2023 that were of A$30.08 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Stryker Corporation from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | A$35.81 B | -1.41% |
| 2024 | A$36.32 B | 20.74% |
| 2023 | A$30.08 B | 10.98% |
| 2022 | A$27.11 B | 14.89% |
| 2021 | A$23.59 B | 26.44% |
| 2020 | A$18.66 B | -12.21% |
| 2019 | A$21.25 B | 10.11% |
| 2018 | A$19.30 B | 21.12% |
| 2017 | A$15.93 B | 1.45% |
| 2016 | A$15.71 B | 15.08% |
| 2015 | A$13.65 B | 15.49% |
| 2014 | A$11.82 B | 16.89% |
| 2013 | A$10.11 B | 21.4% |
| 2012 | A$8.33 B | 2.82% |
| 2011 | A$8.10 B | 12.42% |
| 2010 | A$7.20 B | -3.71% |
| 2009 | A$7.48 B | -21.4% |
| 2008 | A$9.52 B | 37.28% |
| 2007 | A$6.93 B | 3.63% |
| 2006 | A$6.69 B | 0.54% |
| 2005 | A$6.65 B | 20.88% |
| 2004 | A$5.50 B | 12.93% |
| 2003 | A$4.87 B | -8.76% |
| 2002 | A$5.34 B | 4.86% |
| 2001 | A$5.09 B | 24.49% |
| 2000 | A$4.09 B | 27.9% |
| 1999 | A$3.20 B | 77.67% |
| 1998 | A$1.80 B | 19.79% |
| 1997 | A$1.50 B | 31.3% |
| 1996 | A$1.14 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Smith & Nephew
SNN | A$7.08 B | -80.11% | 🇬🇧 UK |
 Medtronic MDT | A$51.46 B | 44.44% | 🇮🇪 Ireland |
 Boston Scientific BSX | A$26.93 B | -24.40% | 🇺🇸 USA |
 Edwards Lifesciences EW | A$8.49 B | -76.14% | 🇺🇸 USA |
 Baxter BAX | A$18.24 B | -48.79% | 🇺🇸 USA |
 Integra LifeSciences IART | A$2.49 B | -93.00% | 🇺🇸 USA |
 Hill-Rom HRC | A$4.63 B | -87.00% | 🇺🇸 USA |
 Owens & Minor
OMI | A$16.45 B | -53.83% | 🇺🇸 USA |
 Waters Corporation WAT | A$4.57 B | -87.15% | 🇺🇸 USA |